72 related articles for article (PubMed ID: 11170300)
1. Role of transforming growth factor-beta1 in prostate cancer.
Wikström P; Damber J; Bergh A
Microsc Res Tech; 2001 Feb; 52(4):411-9. PubMed ID: 11170300
[TBL] [Abstract][Full Text] [Related]
2. [Correlation of FGF2 and TGF-β1 with benign prostatic hyperplasia: Progress in research].
Luo H; Wei Q
Zhonghua Nan Ke Xue; 2022 Sep; 28(9):843-847. PubMed ID: 37839012
[TBL] [Abstract][Full Text] [Related]
3. A lncRNA-immune checkpoint-related gene signature predicts metastasis-free survival in prostate adenocarcinoma.
Ye C; Qin S; Qiu S; Zhao L; Miao J; Chen Y; Zhou T
Transl Androl Urol; 2022 Dec; 11(12):1691-1705. PubMed ID: 36632155
[TBL] [Abstract][Full Text] [Related]
4. Functional roles of E3 ubiquitin ligases in prostate cancer.
Zhao Y; Li J; Chen J; Ye M; Jin X
J Mol Med (Berl); 2022 Aug; 100(8):1125-1144. PubMed ID: 35816219
[TBL] [Abstract][Full Text] [Related]
5. Targeting signaling pathways in prostate cancer: mechanisms and clinical trials.
He Y; Xu W; Xiao YT; Huang H; Gu D; Ren S
Signal Transduct Target Ther; 2022 Jun; 7(1):198. PubMed ID: 35750683
[TBL] [Abstract][Full Text] [Related]
6. PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial.
Narayan V; Barber-Rotenberg JS; Jung IY; Lacey SF; Rech AJ; Davis MM; Hwang WT; Lal P; Carpenter EL; Maude SL; Plesa G; Vapiwala N; Chew A; Moniak M; Sebro RA; Farwell MD; Marshall A; Gilmore J; Lledo L; Dengel K; Church SE; Hether TD; Xu J; Gohil M; Buckingham TH; Yee SS; Gonzalez VE; Kulikovskaya I; Chen F; Tian L; Tien K; Gladney W; Nobles CL; Raymond HE; ; Hexner EO; Siegel DL; Bushman FD; June CH; Fraietta JA; Haas NB
Nat Med; 2022 Apr; 28(4):724-734. PubMed ID: 35314843
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis and Anti-Angiogenic Treatment in Prostate Cancer: Mechanisms of Action and Molecular Targets.
Ioannidou E; Moschetta M; Shah S; Parker JS; Ozturk MA; Pappas-Gogos G; Sheriff M; Rassy E; Boussios S
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576107
[TBL] [Abstract][Full Text] [Related]
8. Effect of a Single Bout of Aerobic Exercise on Kynurenine Pathway Metabolites and Inflammatory Markers in Prostate Cancer Patients-A Pilot Randomized Controlled Trial.
Schenk A; Esser T; Knoop A; Thevis M; Herden J; Heidenreich A; Bloch W; Joisten N; Zimmer P
Metabolites; 2020 Dec; 11(1):. PubMed ID: 33374836
[TBL] [Abstract][Full Text] [Related]
9. TGF-β and microRNA Interplay in Genitourinary Cancers.
Boguslawska J; Kryst P; Poletajew S; Piekielko-Witkowska A
Cells; 2019 Dec; 8(12):. PubMed ID: 31842336
[TBL] [Abstract][Full Text] [Related]
10. TGF-BETA IN THE NATURAL HISTORY OF PROSTATE CANCER.
Ahel J; Hudorović N; Vičić-Hudorović V; Nikles H
Acta Clin Croat; 2019 Mar; 58(1):128-138. PubMed ID: 31363335
[TBL] [Abstract][Full Text] [Related]
11. Asporin is a stromally expressed marker associated with prostate cancer progression.
Rochette A; Boufaied N; Scarlata E; Hamel L; Brimo F; Whitaker HC; Ramos-Montoya A; Neal DE; Dragomir A; Aprikian A; Chevalier S; Thomson AA
Br J Cancer; 2017 Mar; 116(6):775-784. PubMed ID: 28152543
[TBL] [Abstract][Full Text] [Related]
12. Effects of cisplatin on the LSD1-mediated invasion and metastasis of prostate cancer cells.
Chen ZY; Chen H; Qiu T; Weng XD; Guo J; Wang L; Liu XH
Mol Med Rep; 2016 Sep; 14(3):2511-7. PubMed ID: 27484796
[TBL] [Abstract][Full Text] [Related]
13. Missing link between microRNA and prostate cancer.
Gill BS; Alex JM; Navgeet ; Kumar S
Tumour Biol; 2016 May; 37(5):5683-704. PubMed ID: 26822307
[TBL] [Abstract][Full Text] [Related]
14. Restoring TGFβ1 pathway-related microRNAs: possible impact in metastatic prostate cancer development.
Santos JI; Teixeira AL; Dias F; Gomes M; Nogueira A; Assis J; Medeiros R
Tumour Biol; 2014 Jul; 35(7):6245-53. PubMed ID: 24763824
[TBL] [Abstract][Full Text] [Related]
15. TGF-β cascade regulation by PPP1 and its interactors -impact on prostate cancer development and therapy.
Korrodi-Gregório L; Silva JV; Santos-Sousa L; Freitas MJ; Felgueiras J; Fardilha M
J Cell Mol Med; 2014 Apr; 18(4):555-67. PubMed ID: 24629090
[TBL] [Abstract][Full Text] [Related]
16. TGFβ1 Leu10Pro polymorphism contributes to the development of prostate cancer: evidence from a meta-analysis.
Cai Q; Tang Y; Zhang M; Shang Z; Li G; Tian J; Jiang N; Quan C; Niu Y
Tumour Biol; 2014 Jan; 35(1):667-73. PubMed ID: 23975370
[TBL] [Abstract][Full Text] [Related]
17. Improvement of a predictive model of castration-resistant prostate cancer: functional genetic variants in TGFβ1 signaling pathway modulation.
Teixeira AL; Gomes M; Nogueira A; Azevedo AS; Assis J; Dias F; Santos JI; Lobo F; Morais A; Maurício J; Medeiros R
PLoS One; 2013; 8(8):e72419. PubMed ID: 23951322
[TBL] [Abstract][Full Text] [Related]
18. Inhibitor of differentiation 1 (Id1) and Id3 proteins play different roles in TGFβ effects on cell proliferation and migration in prostate cancer cells.
Strong N; Millena AC; Walker L; Chaudhary J; Khan SA
Prostate; 2013 May; 73(6):624-33. PubMed ID: 23060149
[TBL] [Abstract][Full Text] [Related]
19. Emerging critical role of molecular testing in diagnostic genitourinary pathology.
Netto GJ; Cheng L
Arch Pathol Lab Med; 2012 Apr; 136(4):372-90. PubMed ID: 22458900
[TBL] [Abstract][Full Text] [Related]
20. Loss of function of e-cadherin in embryonic stem cells and the relevance to models of tumorigenesis.
Mohamet L; Hawkins K; Ward CM
J Oncol; 2011; 2011():352616. PubMed ID: 21197469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
